Old Web
English
Sign In
Acemap
>
Paper
>
Treatment Of IPF With The Tyrosine Kinase Inhibitor BIBF 1120: Patient-Reported Outcomes In The TOMORROW Trial
Treatment Of IPF With The Tyrosine Kinase Inhibitor BIBF 1120: Patient-Reported Outcomes In The TOMORROW Trial
2012
Kevin K. Brown
Luca Richeldi
Ulrich Costabel
Kevin R. Flaherty
Dong Soon Kim
Paul W. Noble
Ganesh Raghu
Moisés Selman
Michèle Brun
Matthias Klueglich
Harold Staines
Roland M. du Bois
Keywords:
Oncology
Intensive care medicine
Tyrosine kinase inhibitor BIBF 1120
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
6
Citations
NaN
KQI
[]